    Sentence 1: The US. Food and Drug  Administration rejected ImClone 's original  application in December 2001 , saying the trial  had been sloppily conducted    Sentence 2: The Food and Drug Administration  ultimately denied ImClone ’s drug application in  December 2001, saying that an Erbitux clinical  trial was deficient *